-
Traxanox sodium
- names:
5H-(1)Benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1H-tetrazol-5-yl)-, sodium salt
- CAS号:
70502-82-8
MDL Number: - MF(分子式): C13H5ClN5NaO2 MW(分子量): 321.6558
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | 5H-(1)Benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1H-tetrazol-5-yl)-, sodium salt |
| 英文别名 | Traxanox sodium; Y 12141; Y-12141; Y12141. |
| CAS号 | 70502-82-8 |
| Inchi | InChI=1S/C13H5ClN5O2.Na/c14-9-5-6(12-16-18-19-17-12)4-8-10(20)7-2-1-3-15-13(7)21-11(8)9;/h1-5H;/q-1;+1 |
| InchiKey | LAEVCGNXDKGJQI-UHFFFAOYSA-N |
| 分子式 Formula | C13H5ClN5NaO2 |
| 分子量 Molecular Weight | 321.6558 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | Traxanox sodium(CAS:70502-82-8):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | Traxanox sodium is a biochemical. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Fujimura A, Ebihara A, Hino N, Koike Y. Effects of traxanox sodium on blood pressure and serum uric acid in hypertensive patients: a preliminary study. J Clin Pharmacol. 1989 Apr;29(4):327-30. PubMed PMID: 2723121. |
| [2]Hisadome M, Terasawa M, Goto K, Kawazoe Y, Okumoto T. Stimulation of phagocytic activity of leukocytes and macrophages by traxanox sodium in mice and rats. Jpn J Pharmacol. 1989 Feb;49(2):275-84. PubMed PMID: 2733265. |
| [3] Terasawa M, Tomomatsu N, Maruyama Y. [Effects of traxanox sodium on experimental nasal allergy]. Nihon Yakurigaku Zasshi. 1988 Jul;92(1):11-6. Japanese. PubMed PMID: 3220322. |
| [4] Ebihara A, Tsuru M, Ohashi K, Fujimura A, Kondo K. Diuretic and uricosuric effects of traxanox sodium in healthy subjects. Single dose study. Arzneimittelforschung. 1987 Dec;37(12):1388-91. PubMed PMID: 3329516. |
| [5] Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol. 1987 Feb;90(2):421-9. PubMed PMID: 2435353; PubMed Central PMCID: PMC1916952. |
6: Terasawa M, Imayoshi T, Maruyama Y, Abe C. [Effect of traxanox sodium on inflammatory response]. Nihon Yakurigaku Zasshi. 1985 Nov;86(5):329-40. Japanese. PubMed PMID: 2867959.7: Terasawa M, Imayoshi T, Goto K. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis]. Nihon Yakurigaku Zasshi. 1983 Jul;82(1):93-101. Japanese. PubMed PMID: 6194083.8: Nakamura T, Miura Y, Aihara K, Satoh H, Goto K, Tsumagari T. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system]. Nihon Yakurigaku Zasshi. 1983 Jul;82(1):79-92. Japanese. PubMed PMID: 6137441.9: Goto K, Osuga K, Haga K, Tsumagari T. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system]. Nihon Yakurigaku Zasshi. 1983 May;81(5):343-63. Japanese. PubMed PMID: 6629211.10: Ikegami K, Hirano S, Hasegawa G. The effects of traxanox sodium of cyclic AMP phosphodiesterase and the concentration of cyclic AMP in the plasma of rats. Chem Pharm Bull (Tokyo). 1983 Feb;31(2):752-5. PubMed PMID: 6309423.1
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


